Rhythm Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.About RYTM
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases.
RYTM Key Statistics
Stock Snapshot
With a market cap of 6.2B, Rhythm Pharmaceuticals(RYTM) trades at $90.01. The stock has a price-to-earnings ratio of -28.69.
As of 2026-10-27, Rhythm Pharmaceuticals(RYTM) stock has fluctuated between $88.72 and $90.60. The current price stands at $90.01, placing the stock +1.4% above today's low and -0.7% off the high.
The Rhythm Pharmaceuticals(RYTM)'s current trading volume is 19.46K, compared to an average daily volume of 533.05K.
During the past year, Rhythm Pharmaceuticals(RYTM) stock moved between $74.50 at its lowest and $122.20 at its peak.
During the past year, Rhythm Pharmaceuticals(RYTM) stock moved between $74.50 at its lowest and $122.20 at its peak.
RYTM News
Rhythm Pharmaceuticals has launched IMCIVREE in Japan for acquired hypothalamic obesity after inclusion on the National Health Insurance drug price list, suppor...
Analyst ratings
90%
of 20 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.